Director resigns from CytoDyn Board, joins Scientific Advisory Board

CytoDyn Inc.

Dr. Harish Seethamraju resigned from the Board of Directors effective December 15, 2021.
Resignation due to other pre-existing professional commitments, not due to any disagreement.
Dr. Seethamraju agreed to join CytoDyn's Scientific Advisory Board to continue providing support.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Harish Seethamraju

Director

CYDY · CytoDyn Inc.

Effective: 2021-12-15
Filed: December 21, 2021, 6:59 PM ET

On December 15, 2021, Harish Seethamraju, M.D., notified the Chairman of the Board of CytoDyn Inc. (the “Company”) of his resignation from the Board of Directors, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Harish Seethamraju resigned as Director at CytoDyn Inc..

Action: resigned
Role: Director

Exact text from the filing

On December 15, 2021, Harish Seethamraju, M.D., notified the Chairman of the Board of CytoDyn Inc. (the “Company”) of his resignation from the Board of Directors, effective immediately.

View on SEC.gov

CytoDyn Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-363683

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.